NCT03221387View on ClinicalTrials.gov

Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 10, 2017

Primary Completion Date

December 15, 2019

Study Completion Date

December 15, 2019

Conditions
Pulmonary Disease, Chronic ObstructiveHypercapniaHypoxia
Interventions
DEVICE

Humidified nasal high flow with oxygen

The AIRVO 2 is for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases.

Trial Locations (1)

19140

Temple University Hospital, Philadelphia

All Listed Sponsors
collaborator

Fisher and Paykel Healthcare

INDUSTRY

lead

Temple University

OTHER

NCT03221387 - Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients | Biotech Hunter | Biotech Hunter